2012
Conflict and health, (2012).6 1 10.1186/1752-1505-6-2.
2012
PloS one, (2012).7 3 10.1371/journal.pone.0033564.
2012
PLoS medicine, (2012).9 11 10.1371/journal.pmed.1001340.
2012
International health, (2012).4 2 10.1016/j.inhe.2012.01.001.
2012
International journal of epidemiology, (2012).42 1 10.1093/ije/dys215.
2012
Journal of health, population, and nutrition, (2012).30 2 10.3329/jhpn.v30i2.11315.
2012
BMC nursing, (2012).11 1 10.1186/1472-6955-11-3.
2012
Lancet, (2012).380 9856 10.1016/S0140-6736(12)61910-2.
2012
Current opinion in infectious diseases, (2012).25 3 10.1097/qco.0b013e3283529af9.
Could HSV-2 suppressive therapy using valacyclovir be a cost-effective strategy for reducing HIV disease progression and transmission among HIV-1 infected women in South Africa?.
2012
XIX International AIDS Conference (2012).